Page last updated: 2024-10-29

ketamine and Brachial Paresis

ketamine has been researched along with Brachial Paresis in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ilahi, Z1
Janardhan, S1
Dave, M1
Khariton, M1
Feuer, P1
Venkataraman, A1
Romanos-Sirakis, E1
Agarwal, R1
Roitman, KJ1
Stokes, M1

Other Studies

2 other studies available for ketamine and Brachial Paresis

ArticleYear
Ketamine as an Adjunct for Treatment of Methotrexate-induced Neurotoxicity.
    Journal of pediatric hematology/oncology, 2022, Mar-01, Volume: 44, Issue:2

    Topics: Child; Homocysteine; Humans; Ketamine; Methotrexate; Neurotoxicity Syndromes; Paresis

2022
Improvement of intraoperative somatosensory evoked potentials by ketamine.
    Paediatric anaesthesia, 1998, Volume: 8, Issue:3

    Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Astrocytoma; Child; Evoked Potentials, Somatose

1998